WSGR logoWSGR logo
WSGR logo
  • Experience
  • People
  • Insights
  • About Us
  • Careers

  • Practice Areas
  • Industries

  • Corporate
  • Intellectual Property
  • Litigation
  • Patents and Innovations
  • Regulatory
  • Technology Transactions

  • Capital Markets
  • Corporate Governance
  • Corporate Life Sciences
  • Derivatives
  • Emerging Companies and Venture Capital
  • Employee Benefits and Compensation
  • Energy and Climate Solutions
  • Executive Advisory Program
  • Finance and Structured Finance
  • Fund Formation
  • Greater China
  • Mergers & Acquisitions
  • Private Equity
  • Public Company Representation
  • Real Estate
  • Restructuring
  • Shareholder Engagement and Activism
  • Tax
  • U.S. Expansion

  • Special Purpose Acquisition Companies (SPACs)

  • Environmental, Social, and Governance

  • AI and Data Center Infrastructure
  • Energy Regulation and Competition
  • Project Development and M&A
  • Project Finance and Tax Credit Transactions
  • Sustainability and Decarbonization
  • Transportation Electrification

  • U.S. Expansion Library and Resources

  • Post-Grant Review
  • Trademark and Advertising

  • Antitrust Litigation
  • Arbitration
  • Board and Internal Investigations
  • Class Action Litigation
  • Commercial Litigation
  • Consumer Litigation
  • Corporate Governance Litigation
  • Employment Litigation
  • Executive Branch Updates
  • Government Investigations
  • Internet Strategy and Litigation
  • Patent Litigation
  • Securities Litigation
  • State Attorneys General
  • Supreme Court and Appellate Practice
  • Trade Secret Litigation
  • Trademark and Copyright Litigation
  • Trial
  • White Collar Crime

  • Advertising, Promotions, and Marketing
  • Antitrust and Competition
  • Committee on Foreign Investment in the U.S. (CFIUS)
  • Communications
  • Data, Privacy, and Cybersecurity
  • Export Control and Sanctions
  • FCPA and Anti-Corruption
  • FDA Regulatory, Healthcare, and Consumer Products
  • Federal Trade Commission
  • Fintech and Financial Services
  • Government Contracts
  • National Security and Trade
  • Payments
  • State Attorneys General
  • Strategic Risk and Crisis Management
  • Tariffs, Customs, and Import Compliance

  • Antitrust and Intellectual Property
  • Antitrust Civil Enforcement
  • Antitrust Compliance and Business Strategy
  • Antitrust Criminal Enforcement
  • Antitrust Litigation
  • Antitrust Merger Clearance
  • European Competition Law
  • Third-Party Merger and Non-Merger Antitrust Representation

  • Anti-Money Laundering
  • Foreign Ownership, Control, or Influence (FOCI)
  • Team Telecom

  • AI in Healthcare
  • Animal Health
  • Artificial Intelligence and Machine Learning
  • Aviation
  • Biotech
  • Blockchain and Cryptocurrency
  • Clean Energy
  • Climate and Clean Technologies
  • Communications and Networking
  • Consumer Products and Services
  • Data Storage and Cloud
  • Defense Tech
  • Diagnostics, Life Science Tools, and Deep Tech
  • Digital Health
  • Digital Media and Entertainment
  • Electronic Gaming
  • Fintech and Financial Services
  • FoodTech and AgTech
  • Global Generics
  • Internet
  • Life Sciences
  • Medical Devices
  • Mobile Devices
  • Mobility
  • NewSpace
  • Quantum Computing
  • Semiconductors
  • Software

  • Offices
  • Country Desks
  • Events
  • Community
  • Our Diversity
  • Sustainability
  • Our Values
  • Board of Directors
  • Management Team

  • Austin
  • Boston
  • Boulder
  • Brussels
  • Century City
  • Hong Kong
  • London
  • Los Angeles
  • New York
  • Palo Alto
  • Salt Lake City
  • San Diego
  • San Francisco
  • Seattle
  • Shanghai
  • Washington, D.C.
  • Wilmington, DE

  • Law Students
  • Judicial Clerks
  • Experienced Attorneys
  • Patent Agents
  • Business Professionals
  • Alternative Legal Careers
  • Contact Recruiting
Navigating the Corporate Practice of Medicine: Compliance Essentials and Recent Developments
WSGR Events
Thursday, July 16, 2026
9:00 - 10:00 AM PT

Webinar

Add to calendarRegister for event

The corporate practice of medicine (CPOM) doctrine restricts the ability of non-physician entities to employ or engage physicians or direct the practice of medicine in certain states. The CPOM doctrine’s rules, which are anything but uniform, make it a threshold issue for any digital health company with a care delivery component. Join Wilson Sonsini for its semi-annual training for digital health executives, designed to keep them current on both the fundamentals and the latest developments shaping CPOM compliance. Each session addresses the core framework and spotlights what has changed since the last installment, so your team can stay ahead of the fast-moving regulatory landscape.

This series is built for founders, C-suite leaders, physician owners, general counsel, and compliance officers who need a clear, recurring touchpoint on CPOM risk. It’s equally valuable for investors in the digital health space who want to understand how these structures work and where the compliance lines fall. We recommend it as standing executive training for any organization operating MSO-PC (management services organization-professional corporation) structures.

Each session covers:

  • CPOM foundations — The core prohibitions, the policy rationale, and how the doctrine operates across key jurisdictions
  • Structuring essentials — How MSOs, PCs, and affiliated entity structures are used to maintain compliance
  • State spotlight and emerging trends — An in-depth look at recent legislative, regulatory, case law, and enforcement developments in active jurisdictions
  • Practical takeaways — What concrete steps organizations should be taking now to strengthen compliance and reduce enforcement risk

Spotlight This Session: California and Oregon

This session will take a close look at the California and Oregon developments reshaping the field, including the California Attorney General's amicus brief in Art Center Holdings v. WCE CA Art (taking the position that MSO succession and stock transfer restriction rights to replace a physician owner can violate CPOM even if never exercised), the California Attorney General's recent settlement with Aspen Dental, and the Oregon SB 951 challenge in Eugene Emergency Physicians v. PeaceHealth (the first private enforcement action under what is widely considered to be the strictest CPOM law in the country).

Why It Matters

CPOM compliance is not just a one-time paperwork exercise—it requires ongoing effort. A non-compliant structure can trigger regulatory penalties and unlicensed-practice exposure, and put licensure, payor relationships, and company valuation at risk. It can also drive investment outcomes, where sophisticated investors treat CPOM compliance as a fundamental diligence and risk factor, which makes a clean, defensible structure increasingly important to raising capital and reaching a successful exit.

Contacts

Adam Pilkington

apilkington@wsgr.com

Presenters

Andrea Linna
Partner

Andrea Linna is a partner at Wilson Sonsini Goodrich & Rosati, where she is a member of the firm’s digital health industry group and its healthcare practice. With more than a decade dedicated to healthcare law, Andrea exclusively represents digital health and healthcare IT clients, from emerging companies to established industry players, investors, and healthcare systems. Andrea guides her clients through the patchwork of federal and state laws that apply to digital health companies, addressing issues such as corporate practice of medicine, Stark Law compliance, Anti-Kickback Statute considerations, fee splitting, billing Medicare and Medicaid, contracting with commercial payors, value-based care arrangements, artificial intelligence, remote patient monitoring, online prescribing, scope of practice, and licensing requirements.

View Profile
Nawa Lodin
Associate
Washington, D.C.

Nawa Lodin is an associate in the Washington, D.C., office of Wilson Sonsini Goodrich & Rosati, where she is a member of the firm’s digital health industry group and healthcare practice. She advises healthcare, digital health, life sciences, and technology companies on complex healthcare regulatory and transactional matters, with a particular focus on artificial intelligence and machine learning in healthcare, telehealth, corporate practice of medicine, and federal and state fraud and abuse laws, including the Anti-Kickback Statute and Stark Law.

View Profile
Seamus Taylor
Associate
Washington, D.C.

Seamus Taylor is an associate in the Washington, D.C., office of Wilson Sonsini Goodrich & Rosati, where he is a member of the firm’s digital health industry group and its healthcare practice. Seamus helps clients ranging from start-ups to publicly traded companies navigate the complex world of health law.

View Profile
  • people
  • insights
  • about us
  • careers
  • Binder
  • Alumni
  • Mailing List Signup
  • Client FTP Portal
  • Privacy Policy
  • Terms of Use
  • Accessibility
WSGR logo
Twitter
LinkedIn
Facebook
Instagram
Youtube
Copyright © 2026 Wilson Sonsini Goodrich & Rosati. All Rights Reserved.